Hanmi Group has been awarded a commendation from the Korean Red Cross for its 46 years of dedication to the "Love Blood Donation Campaign." Through voluntary participation from its employees, the company has donated a total of 3.79 million cc of blood, establishing itself as a leader in social contribution within the pharmaceutical industry.
On June 12, Hanmi Science, the holding company of Hanmi Group, received the commendation during the "2026 Blood Donor Day Ceremony" held at the Sky Art Hall in Gangseo-gu, Seoul. The event was attended by Jeong Gyeong-sil, Director of Health and Medical Policy at the Ministry of Health and Welfare, and Kim Hong-guk, Acting President of the Korean Red Cross, among other officials.
The Love Blood Donation Campaign began in November 1980 when Im Sung-ki, the founder of Hanmi Pharmaceutical, participated in the opening of a blood donation center at City Hall Station in Seoul. Since then, 11,857 employees have participated, contributing to a cumulative blood donation of 3.79 million cc.
After donating blood, employees provide certificates that are then given to colleagues in need of emergency transfusions and to patient organizations such as the Korean Blood Cancer Association. The total number of donated blood donation certificates has reached 6,247.
Hanmi Group continues to engage in various social contribution activities based on its management philosophy of "respect for human beings" and "value creation." Shim Byeong-hwa, Vice President in charge of CSR at Hanmi Group, stated, "We will fulfill our mission as a pharmaceutical company by continuing our social contribution activities to create a healthy and warm society."
* This article has been translated by AI.
Copyright ⓒ Aju Press All rights reserved.